Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

0.7827 +0.0056 (+0.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,238,024
Open 0.7846
Bid (Size) 0.7701 (168)
Ask (Size) 0.7890 (50)
Prev. Close 0.7771
Today's Range 0.7400 - 0.8000
52wk Range 0.6134 - 3.012
Shares Outstanding 348,875,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agenus Reports Third Quarter 2023 Results
From Agenus Inc.
Via Business Wire
Agenus's Earnings Outlook
Via Benzinga

Performance

YTD
-66.77%
-66.77%
1 Month
-5.77%
-5.77%
3 Month
-43.69%
-43.69%
6 Month
-51.08%
-51.08%
1 Year
-69.79%
-69.79%

More News

Read More
Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update
From Agenus Inc.
Via Business Wire
Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
From Agenus Inc.
Via Business Wire
ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes
From Agenus Inc.
Via Business Wire
Agenus Completes Enrollment in Randomized Phase 2 Clinical Trial of Botensilimab/Balstilimab in Advanced Colorectal Cancer
From Agenus Inc.
Via Business Wire
Agenus To Host BOT/BAL Program Update at ESMO 2023
From Agenus Inc.
Via Business Wire
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Agenus Inc.
Via Business Wire
HEICO, Canaan And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
Via The Motley Fool
Agenus to Participate in September Investor Conferences
From Agenus Inc.
Via Business Wire
Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers
From Agenus Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
SaponiQx Announces Breakthrough in Scaling Up of STIMULON™ Cultured Plant Cell Adjuvant
From SaponiQx
Via Business Wire
Agenus Reports Second Quarter 2023 Results
From Agenus Inc.
Via Business Wire
Agenus Botensilimab/Balstilimab Data Update in Sarcomas Selected for Oral Presentation at ESMO 2023
From Agenus Inc.
Via Business Wire
Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update
From Agenus
Via Business Wire
Agenus Expands Executive Leadership Team
From Agenus Inc.
Via Business Wire
ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer
From Agenus
Via Business Wire
2 Low-Priced Stocks That Could Make You Richer
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
Via Benzinga
Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO
From Agenus Inc.
Via Business Wire
Agenus Announces Virtual Annual Shareholders Meeting
From Agenus
Via Business Wire
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.